AMEXCAP’s Annual Private Equity Summit.

AMEXCAP’s Annual Private Equity Summit.

Come and Join us!

Every year since 2006, AMEXCAP organizes the most important Private Equity event in Mexico: AMEXCAP’s Annual Private Equity Summit. This key meeting point brings together the most dynamic and important players in the industry.

Clearly 2018 will bring new challenges for Mexico like the resumption of the NAFTA negotiation rounds, as well as the election of the new President. However, we believe in the great potential of the country and 2017 was a great example of Mexico’s strength, as it faced many adversities, emerging victorious from pessimistic economic forecasts, Trump’s protectionist policies and two major earthquakes.

This Summit disseminates private equity investment opportunities in Mexico, it is a pleasure for ARC Capital being part of this great event. We have been invited by AMEXCAP to participate in order to meet the most important people from the ecosystem, looking forward to strength our business network, having the opportunity to find potential LP’s for our fintech fund, impulse public listings in the U.S. and bring in Chinese investment opportunities.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission